The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II/III study of SM-88 in patients with metastatic pancreatic cancer.
 
Vincent Chung
Consulting or Advisory Role - Apeiron Biologics; Gritstone Bio; Ipsen; Westwood Bioscience
Speakers' Bureau - Celgene; Ipsen
Research Funding - Merck (Inst); Roche (Inst)
 
Huan Dong
No Relationships to Disclose
 
Semmie Kim
Employment - Tyme
 
Ronald Lee Korn
Employment - Imaging Endpoints
Stock and Other Ownership Interests - Globavir; Teladoc
Consulting or Advisory Role - Dracen; ImaginAB
Research Funding - Tyme
Patents, Royalties, Other Intellectual Property - Determination of Breast Cancer Malignancy using Textural analysis
Travel, Accommodations, Expenses - Deciphera; ImaginAb; Kite/Gilead
 
Anne M. Noonan
Consulting or Advisory Role - Exelixis; Helsinn Healthcare; QED Therapeutics
 
Paul Eliezer Oberstein
Consulting or Advisory Role - BTG; Ipsen; Merck; TYME
Research Funding - Merck (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Merck
 
Allyson J. Ocean
Consulting or Advisory Role - Celgene; Tyme
Speakers' Bureau - Daiichi Sankyo
Travel, Accommodations, Expenses - Daiichi Sankyo; Tyme
 
Shubham Pant
Honoraria - 4D Pharma
Consulting or Advisory Role - TYME; Xencor; Zymeworks
Research Funding - ArQule (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Onco Response (Inst); RedHill Biopharma (Inst); Rgenix (Inst); Sanofi/Aventis (Inst); Xencor (Inst)
 
Vincent J. Picozzi
Stock and Other Ownership Interests - Abbvie; Amgen Astellas BioPharma; Gilead Sciences; Johnson & Johnson
Consulting or Advisory Role - Abbvie; Cornerstone Pharmaceuticals; Gilead Sciences; Halozyme
Research Funding - Aduro Biotech; Celgene; FibroGen; Immunomedics; OncoMed
 
Philip Agop Philip
Honoraria - Array BioPharma; AstraZeneca; Bayer; Blueprint Medicines; Celgene; Ipsen; Merck; SynCoreBio; TriSalus Life Sciences
Consulting or Advisory Role - Celgene; Daiichi Sankyo; Ipsen; Merck; SynCoreBio; Taiho Pharmaceutical; TriSalus Life Sciences
Speakers' Bureau - Bayer; Celgene; Incyte; Ipsen; Novartis
Research Funding - Advanced Accelerator Applications (Inst); ASLAN Pharmaceuticals (Inst); Bayer (Inst); boston biomedical (Inst); Caris Life Sciences (Inst); Caris Life Sciences (Inst); Genentech (Inst); halozyme (Inst); Immunomedics (Inst); incyte (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); merus (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); Plexxikon (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); tyme (Inst); TYME (Inst)
Travel, Accommodations, Expenses - Abbvie; celgene; Rafael Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Caris MPI; Rafael Pharmaceuticals
 
Alexander Rosemurgy
No Relationships to Disclose
 
Benjamin R. Tan
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst); Roche/Genentech (Inst); Sillajen (Inst); tyrogenex (Inst)
 
Andrea Wang-Gillam
Employment - Jacobio
Stock and Other Ownership Interests - Jacobio
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; Inxmed; Inxmed; Jacobio; Merck; Repugene; Tyme
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); CTI (Inst); Gossamer Bio (Inst); Hutchison MediPharma (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Newlink Genetics (Inst); pfizer (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Verastem (Inst); Xcovery (Inst)
 
Steve Wong
No Relationships to Disclose
 
Giuseppe Del Priore
Employment - Tyme
Leadership - Tyme
Stock and Other Ownership Interests - Tyme
Consulting or Advisory Role - Tyme